An agreement (the terms of which are set out in detail in the "Settlement Agreement") has been reached between the Petitioner (the individual who brought the Class Action) and BCS in the Class Action. In order for the Settlement Agreement to become effective, it must be approved by the Superior Court of Quebec.

For further information please read the:

Notice of Hearing for Approval of Proposed Settlement of Bishop's College School Class Action Concerning Sexual and any Physical, Mental or Psychological Abuse.

Settlement Agreement

McPhadden Samac Tuovi have commenced a proposed class action against Johnson & Johnson and related companies relative to the collagen dermal filler Evolence. The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation.

Media Release.

For further information and instructions.

On behalf of two Mississauga, Ontario plaintiffs, McPhadden Samac Tuovi has commenced a proposed class action against GLAXOSMITHKLINE INC. and related companies ("GSK") relative to the drug Rosiglitazone which is widely used to lower blood sugar levels in people who suffer from Type II diabetes mellitus.  Rosiglitazone is marketed and sold by DSK under the brand names Avandia™, Avandamet™, and Avandaryl™. 

For further information and instructions.

A hearing will be held June 4, 2009 for the conversion of this proceeding into an individual action.

Click here to read the Notice of Hearing.